FDA Revokes Clearance For Premature Birth Drug Makena
By Kelly Lienhard ( April 6, 2023, 8:02 PM EDT) -- The U.S. Food and Drug Administration announced on Thursday that it would be pulling a medication intended to reduce the risk of preterm birth off the market after it found that a post marketing confirmatory study did not show the drug to be effective....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.